中医药防治心肌缺血再灌注损伤的研究进展  

Research Progress on the Prevention and Treatment of Myocardial Ischemia and Reperfusion Injury by Traditional Chinese Medicine

作　　者：黄婷[1,2] 李绍旦 高路[2] 王鹏[1] 刘毅[2] 杨明会[2] HUANG Ting;LI Shao-dan;GAO Lu;WANG Peng;LIU Yi;YANG Ming-hui(Beijing University of Traditional Chinese Medicine,Beijing 100029,China;Chinese People's Liberation Army General Hospital,Beijing 100853,China)

机构地区：[1]北京中医药大学,北京100029 [2]中国人民解放军总医院,北京100853

出　　处：《医学信息》2018年第4期31-33,37,共4页Journal of Medical Information

基　　金：国家重点基础研究发展计划(973计划)(编号:2012CB518601)

摘　　要：中医药是中华民族的宝贵财富,其治疗理念正逐渐被世界所接受,中医以疏通经脉、渗灌气血、濡养心神指导临床,其文献中无心肌缺血再灌注损伤一词,依据其病理过程中表现出的症状,多归属于中医的"胸痹""心悸"和"真心痛"等范畴,现将MIRI的病理机制及中医药治疗进行整理,了解中医药对MIRI的干预治疗,从而为临床诊疗提供应用价值。Traditional Chinese medicine is a valuable asset to the Chinese nation.Its concept of treatment is gradually being accepted by the world.Traditional Chinese medicine(TCM)is designed to unblock meridians and infiltrate qi and blood.It guides the clinical practice.There is no evidence of myocardial ischemia-reperfusion injury in its literature.According to its pathological process showed symptoms,mostly attributed to traditional Chinese medicine"chest paralysis,""heart palpitations"and"true heartache"and other fields,now MIRI pathological mechanism and treatment of traditional Chinese medicine to organize and understand the traditional Chinese medicine MIRI intervention treatment,so as to provide clinical value for clinical treatment.

关 键 词：心肌缺血再灌注损伤 中医药 研究进展 病理机制 

分 类 号：R259[医药卫生—中西医结合]